Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C

Sara Ullsten1, Kine Østnes Hansen1, Guillaume Axel Petit1

  • 1MARBIO, UiT - The Arctic University of Norway, Breivika, 9037, Tromsø, Norway.

Scientific Reports
|January 8, 2025
PubMed

Insights

Breitfussin C protects pancreatic beta cells from cytokine damage and promotes proliferation by inhibiting DYRK kinases. This natural compound shows potential for developing new diabetes therapies.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Marine Pharmacology

Background:

  • Pro-inflammatory cytokines induce pancreatic beta cell death and dysfunction, contributing to diabetes onset.
  • Targeting cytokine signaling pathways is a potential therapeutic strategy for diabetes.
  • Breitfussin C (BfC) is a natural compound from Thuiaria breitfussi with potential beta cell protective effects.

Purpose of the Study:

  • To investigate the protective and proliferative effects of breitfussin C (BfC) on pancreatic beta cells exposed to pro-inflammatory cytokines.
  • To explore the mechanism of BfC's action, including its effects on DYRK kinases and cell cycle regulation.

Main Methods:

  • Utilized the beta cell line RIN-M5F for experiments.
  • Assessed cell viability (MTS assay), apoptosis (caspase 3/7 activity), and proliferation (EdU incorporation, cell cycle distribution).
  • Investigated BfC's inhibition of DYRK kinases using biochemical assays, western blotting, and docking simulations.

Main Results:

  • BfC treatment significantly increased beta cell proliferation and counteracted cytokine-induced proliferation reduction.
  • BfC inhibited DYRK kinases, leading to decreased levels of the cell cycle inhibitor p27KIP.
  • BfC demonstrated a protective effect on beta cells against cytokine-induced damage.

Conclusions:

  • Breitfussin C promotes pancreatic beta cell proliferation via DYRK kinase inhibition.
  • BfC's mechanism involves downregulating the cell cycle inhibitor p27KIP.
  • BfC represents a potential therapeutic starting point for diabetes treatment by enhancing beta cell function and survival.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K